为解决缺乏芽殖酵母 SUMO（Smt3）特异性研究工具及相关修饰机制不明的问题，德国分子生物学研究所的研究人员开展了针对 Smt3 的 DARPin 亲和探针研究，发现了 DNA 损伤诱导的、不依赖单链 DNA 的染色质 SUMO 化修饰，为相关研究提供了新工具和见解。 在细胞的生命 ...

53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics ("Molecular Partners" or ...

DLL3 targeting Radio-DARPin MP0712 to enter first-in-human study in 2025, pending regulatory clearanceStrategic partnership with Orano Med on ...

Feb. 28, 2025 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin ...

Participation in fireside chats at TD Cowen and Leerink healthcare conferences Call on 2024 financial results on March 7 at 2.00 pm CET (8.00 am ET) ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., ...

DLL3 targeting Radio-DARPin MP0712 to enter first-in-human study in 2025, pending regulatory clearance Strategic partnership with Orano Med on Radio-DARPins now expanded to ten programs MP0533 ...